img

Global Human Serum Albumin Fusion Protein Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Serum Albumin Fusion Protein Drug Market Research Report 2024

Fusion proteins have been well-studied and widely applied in biopharmaceutics. Albumin fusion proteins are simple to construct, easy to purify, and stable to formulate.
According to Mr Accuracy reports’s new survey, global Human Serum Albumin Fusion Protein Drug market is projected to reach US$ 1881.4 million in 2029, increasing from US$ 781.3 million in 2022, with the CAGR of 12.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Serum Albumin Fusion Protein Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Serum Albumin Fusion Protein Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GSK
CSL Behring
Segment by Type
Idelvion
Tanzeum

Segment by Application


Hemophilia
Diabetes
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human Serum Albumin Fusion Protein Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Serum Albumin Fusion Protein Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Idelvion
1.2.3 Tanzeum
1.3 Market by Application
1.3.1 Global Human Serum Albumin Fusion Protein Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hemophilia
1.3.3 Diabetes
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Serum Albumin Fusion Protein Drug Market Perspective (2018-2029)
2.2 Human Serum Albumin Fusion Protein Drug Growth Trends by Region
2.2.1 Global Human Serum Albumin Fusion Protein Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human Serum Albumin Fusion Protein Drug Historic Market Size by Region (2018-2024)
2.2.3 Human Serum Albumin Fusion Protein Drug Forecasted Market Size by Region (2024-2029)
2.3 Human Serum Albumin Fusion Protein Drug Market Dynamics
2.3.1 Human Serum Albumin Fusion Protein Drug Industry Trends
2.3.2 Human Serum Albumin Fusion Protein Drug Market Drivers
2.3.3 Human Serum Albumin Fusion Protein Drug Market Challenges
2.3.4 Human Serum Albumin Fusion Protein Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Serum Albumin Fusion Protein Drug Players by Revenue
3.1.1 Global Top Human Serum Albumin Fusion Protein Drug Players by Revenue (2018-2024)
3.1.2 Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Players (2018-2024)
3.2 Global Human Serum Albumin Fusion Protein Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Serum Albumin Fusion Protein Drug Revenue
3.4 Global Human Serum Albumin Fusion Protein Drug Market Concentration Ratio
3.4.1 Global Human Serum Albumin Fusion Protein Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Serum Albumin Fusion Protein Drug Revenue in 2022
3.5 Human Serum Albumin Fusion Protein Drug Key Players Head office and Area Served
3.6 Key Players Human Serum Albumin Fusion Protein Drug Product Solution and Service
3.7 Date of Enter into Human Serum Albumin Fusion Protein Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Serum Albumin Fusion Protein Drug Breakdown Data by Type
4.1 Global Human Serum Albumin Fusion Protein Drug Historic Market Size by Type (2018-2024)
4.2 Global Human Serum Albumin Fusion Protein Drug Forecasted Market Size by Type (2024-2029)
5 Human Serum Albumin Fusion Protein Drug Breakdown Data by Application
5.1 Global Human Serum Albumin Fusion Protein Drug Historic Market Size by Application (2018-2024)
5.2 Global Human Serum Albumin Fusion Protein Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Human Serum Albumin Fusion Protein Drug Market Size (2018-2029)
6.2 North America Human Serum Albumin Fusion Protein Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Human Serum Albumin Fusion Protein Drug Market Size by Country (2018-2024)
6.4 North America Human Serum Albumin Fusion Protein Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Serum Albumin Fusion Protein Drug Market Size (2018-2029)
7.2 Europe Human Serum Albumin Fusion Protein Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Human Serum Albumin Fusion Protein Drug Market Size by Country (2018-2024)
7.4 Europe Human Serum Albumin Fusion Protein Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Size (2018-2029)
8.2 Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Serum Albumin Fusion Protein Drug Market Size (2018-2029)
9.2 Latin America Human Serum Albumin Fusion Protein Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Human Serum Albumin Fusion Protein Drug Market Size by Country (2018-2024)
9.4 Latin America Human Serum Albumin Fusion Protein Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size (2018-2029)
10.2 Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Human Serum Albumin Fusion Protein Drug Introduction
11.1.4 GSK Revenue in Human Serum Albumin Fusion Protein Drug Business (2018-2024)
11.1.5 GSK Recent Development
11.2 CSL Behring
11.2.1 CSL Behring Company Detail
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Human Serum Albumin Fusion Protein Drug Introduction
11.2.4 CSL Behring Revenue in Human Serum Albumin Fusion Protein Drug Business (2018-2024)
11.2.5 CSL Behring Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human Serum Albumin Fusion Protein Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Idelvion
Table 3. Key Players of Tanzeum
Table 4. Global Human Serum Albumin Fusion Protein Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Human Serum Albumin Fusion Protein Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Human Serum Albumin Fusion Protein Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Human Serum Albumin Fusion Protein Drug Market Share by Region (2018-2024)
Table 8. Global Human Serum Albumin Fusion Protein Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Human Serum Albumin Fusion Protein Drug Market Share by Region (2024-2029)
Table 10. Human Serum Albumin Fusion Protein Drug Market Trends
Table 11. Human Serum Albumin Fusion Protein Drug Market Drivers
Table 12. Human Serum Albumin Fusion Protein Drug Market Challenges
Table 13. Human Serum Albumin Fusion Protein Drug Market Restraints
Table 14. Global Human Serum Albumin Fusion Protein Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Human Serum Albumin Fusion Protein Drug Market Share by Players (2018-2024)
Table 16. Global Top Human Serum Albumin Fusion Protein Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum Albumin Fusion Protein Drug as of 2022)
Table 17. Ranking of Global Top Human Serum Albumin Fusion Protein Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Human Serum Albumin Fusion Protein Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Serum Albumin Fusion Protein Drug Product Solution and Service
Table 21. Date of Enter into Human Serum Albumin Fusion Protein Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Serum Albumin Fusion Protein Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Human Serum Albumin Fusion Protein Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Human Serum Albumin Fusion Protein Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Application (2018-2024)
Table 29. Global Human Serum Albumin Fusion Protein Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Human Serum Albumin Fusion Protein Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Human Serum Albumin Fusion Protein Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Human Serum Albumin Fusion Protein Drug Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Human Serum Albumin Fusion Protein Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Human Serum Albumin Fusion Protein Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Human Serum Albumin Fusion Protein Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Human Serum Albumin Fusion Protein Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Serum Albumin Fusion Protein Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Human Serum Albumin Fusion Protein Drug Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Human Serum Albumin Fusion Protein Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. GSK Company Detail
Table 47. GSK Business Overview
Table 48. GSK Human Serum Albumin Fusion Protein Drug Product
Table 49. GSK Revenue in Human Serum Albumin Fusion Protein Drug Business (2018-2024) & (US$ Million)
Table 50. GSK Recent Development
Table 51. CSL Behring Company Detail
Table 52. CSL Behring Business Overview
Table 53. CSL Behring Human Serum Albumin Fusion Protein Drug Product
Table 54. CSL Behring Revenue in Human Serum Albumin Fusion Protein Drug Business (2018-2024) & (US$ Million)
Table 55. CSL Behring Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Serum Albumin Fusion Protein Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Human Serum Albumin Fusion Protein Drug Market Share by Type: 2022 VS 2029
Figure 3. Idelvion Features
Figure 4. Tanzeum Features
Figure 5. Global Human Serum Albumin Fusion Protein Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Human Serum Albumin Fusion Protein Drug Market Share by Application: 2022 VS 2029
Figure 7. Hemophilia Case Studies
Figure 8. Diabetes Case Studies
Figure 9. Other Case Studies
Figure 10. Human Serum Albumin Fusion Protein Drug Report Years Considered
Figure 11. Global Human Serum Albumin Fusion Protein Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Human Serum Albumin Fusion Protein Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Human Serum Albumin Fusion Protein Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Human Serum Albumin Fusion Protein Drug Market Share by Players in 2022
Figure 15. Global Top Human Serum Albumin Fusion Protein Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum Albumin Fusion Protein Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Human Serum Albumin Fusion Protein Drug Revenue in 2022
Figure 17. North America Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Human Serum Albumin Fusion Protein Drug Market Share by Country (2018-2029)
Figure 19. United States Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Human Serum Albumin Fusion Protein Drug Market Share by Country (2018-2029)
Figure 23. Germany Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Human Serum Albumin Fusion Protein Drug Market Share by Region (2018-2029)
Figure 31. China Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Human Serum Albumin Fusion Protein Drug Market Share by Country (2018-2029)
Figure 39. Mexico Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Human Serum Albumin Fusion Protein Drug Market Share by Country (2018-2029)
Figure 43. Turkey Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Human Serum Albumin Fusion Protein Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. GSK Revenue Growth Rate in Human Serum Albumin Fusion Protein Drug Business (2018-2024)
Figure 46. CSL Behring Revenue Growth Rate in Human Serum Albumin Fusion Protein Drug Business (2018-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries